List of Medivir patents

List of Medivir patents

List of American Seating Company patents

List of Zyomed Corp. patents

List of Origin Wireless, Inc. patents

List of companies in Jeremie Berrebi's investment portfolio

List of awards received by Tommy Lee Jones

Patents where

Current Assignee

Name

is

Medivir

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9828408 HCV polymerase inhibitors	Patent 9828408 was granted and assigned to Medivir on November, 2017 by the United States Patent and Trademark Office.	Medivir	Medivir		United States Patent and Trademark Office	9828408	November 28, 2017
	‌ US Patent 9481703 HCV polymerase inhibitors	Patent 9481703 was granted and assigned to Medivir on November, 2016 by the United States Patent and Trademark Office.	Medivir	Medivir		United States Patent and Trademark Office	9481703	November 1, 2016
	‌ US Patent 10144750 Dioxolane analogues of cytidine for the treatment of cancer	Patent 10144750 was granted and assigned to Medivir on December, 2018 by the United States Patent and Trademark Office.	Medivir	Medivir		United States Patent and Trademark Office	10144750	December 4, 2018
	‌ US Patent 10336780 Dioxolane analogues of uridine for the treatment of cancer	Patent 10336780 was granted and assigned to Medivir on July, 2019 by the United States Patent and Trademark Office.	Medivir	Medivir		United States Patent and Trademark Office	10336780	July 2, 2019
	‌ US Patent 11447511 Dioxolane analogues of uridine for the treatment of cancer			Medivir		United States Patent and Trademark Office	11447511	September 20, 2022
	‌ US Patent 10654877 Dioxolane analogues of uridine for the treatment of cancer		Medivir	Medivir		United States Patent and Trademark Office	10654877	May 19, 2020
	‌ US Patent 10822360 Dioxolane analogues of uridine for the treatment of cancer		Medivir	Medivir		United States Patent and Trademark Office	10822360	November 3, 2020
	‌ US Patent 9650388 Form 2 crystalline polymorph of a salt of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-B]pyrrole-4-carbonyl)-3-methyl-butyl]-4-[5-fluoro-2-(4-methyl-piperazinyl) thiazol-4-yl]-benzamide useful as cysteine protease inhibitor	Patent 9650388 was granted and assigned to Medivir on May, 2017 by the United States Patent and Trademark Office.		Medivir		United States Patent and Trademark Office	9650388	May 16, 2017
	‌ US Patent 9708332 Respiratory syncytial virus inhibitors	Patent 9708332 was granted and assigned to Medivir on July, 2017 by the United States Patent and Trademark Office.		Medivir		United States Patent and Trademark Office	9708332	July 18, 2017
	‌ US Patent 10106571 HCV polymerase inhibitors	Patent 10106571 was granted and assigned to Medivir on October, 2018 by the United States Patent and Trademark Office.	Medivir	Medivir		United States Patent and Trademark Office	10106571	October 23, 2018
	‌ US Patent 10118941 Methods for the preparation of diastereomerically pure phosphoramidate prodrugs	Patent 10118941 was granted and assigned to Medivir on November, 2018 by the United States Patent and Trademark Office.	Medivir	Medivir		United States Patent and Trademark Office	10118941	November 6, 2018

11 results

0 selected

11 results

0 selected